Statin-Induced Autoimmune Necrotizing Myopathy
Statin therapy is a widely prescribed medication class for hypercholesterolemia. In statin-induced autoimmune myopathy, genetically predisposed and at-risk patients can develop antibodies against hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the key enzyme in the production of cholesterol. As a re...
Main Authors: | Sahani Jayatilaka, Kunal Desai, Swarup Rijal, Debra Zimmerman |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-07-01
|
Series: | Journal of Primary Care & Community Health |
Online Access: | https://doi.org/10.1177/21501327211028714 |
Similar Items
-
Statin-Induced Necrotizing Autoimmune Myopathy
by: Brent Gawey, BS, et al.
Published: (2020-03-01) -
A Rare Case of Statin-Induced Necrotizing Autoimmune Myopathy
by: Shirley Shuster, MD, et al.
Published: (2020-03-01) -
Statin-induced necrotizing autoimmune myopathy: an extremely rare adverse effect from statin use
by: Priyadarshani Sharma, et al.
Published: (2019-11-01) -
Statin‐associated necrotizing autoimmune myopathy with concurrent myasthenia gravis
by: Emma Frasson, et al.
Published: (2021-05-01) -
When Should a Patient with Statin-Induced Myopathy Be Re-challenged? A Case of Necrotizing Autoimmune Myopathy
by: Elena Obreja, et al.
Published: (2018-01-01)